Editorial: Terlipressin and MDRO colonisation in cirrhosis-Is there a causal link?

Aliment Pharmacol Ther. 2024 May;59(10):1284-1285. doi: 10.1111/apt.17940.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Humans
  • Liver Cirrhosis* / complications
  • Liver Cirrhosis* / drug therapy
  • Lypressin / adverse effects
  • Lypressin / analogs & derivatives
  • Lypressin / therapeutic use
  • Terlipressin* / therapeutic use
  • Vasoconstrictor Agents* / adverse effects
  • Vasoconstrictor Agents* / therapeutic use

Substances

  • Terlipressin
  • Vasoconstrictor Agents
  • Lypressin